Browsing by Author Rodon, Jordi
Showing results 1 to 3 of 3
| Issue Date | Title | Author(s) |
|---|---|---|
| 1-Mar-2025 | ENDOLUNG trial, part II. A phase II study of the Akt/mTOR inhibitor and autophagy inducer ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with squamous non-small cell lung cancer | Bosch Barrera, Joaquim; Estévez-García, Purificación; Martín-Martorell, Paloma; Sabatier, Renaud; Nadal, Ernest; Sais, Elia; Gascón, Pere; Oaknin, Ana; Rodon, Jordi; Lizcano, José Miguel; Muñoz Guardiola, Pau; Fierro-Durán, Gemma; Pedrós-Gámez, Oriol; Pérez-Montoyo, Hector; Yeste Velasco, Marc; Cortal, Marc; Pérez-Campos, Antonio; Alfón, José; Domènech, Carles; Moran, Teresa |
| 1-Dec-2024 | ENDOLUNG trial. A phase 1/2 study of the Akt/mTOR inhibitor and autophagy inducer Ibrilatazar (ABTL0812) in combination with paclitaxel/carboplatin in patients with advanced/recurrent endometrial cancer | Pérez-Fidalgo, Alejandro; Leary, Alexandra; Estévez-García, Purificación; Sabatier, Renaud; Ray-Coquard, Isabelle; Romeo, Margarita; Barretina Ginesta, Maria Pilar; Gil Martin, Marta; Garralda, Elena; Bosch Barrera, Joaquim; Moran, Teresa; Martin-Martorell, Paloma; Nadal, Ernest; Gascón, Pere; Rodon, Jordi; Lizcano, José Miguel; Muñoz Guardiola, Pau; Fierro-Durán, Gemma; Pedrós-Gámez, Oriol; Pérez-Montoyo, Hector; Yeste Velasco, Marc; Cortal, Marc; Pérez-Campos, Antonio; Alfón, José; Domènech, Carles; Oaknin, Ana |
| 1-Jan-2018 | Phosphatidylinositol 3-Kinase -Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study | Juric, Dejan; Rodon, Jordi; Tabernero Caturla, Josep; Janku, Filip; Burris, Howard A.; Schellens, Jan H. M.; Middleton, Mark R.; Berlin, Jordan; Schuler, Martin; Gil-Martín, Marta; Rugo, Hope S.; Seggewiss Bernhardt, Ruth; Huang, Alan; Bootle, Douglas; Demanse, David; Blumenstein, Lars; Coughlin, Christina; Quadt, Cornelia; Baselga Torres, Josep, 1959- |